Veradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the software maker’s stock.

Veradigm Stock Performance

Veradigm stock opened at $10.51 on Friday. The stock’s fifty day moving average price is $9.65 and its two-hundred day moving average price is $9.39. Veradigm has a one year low of $5.01 and a one year high of $12.66.

Institutional Trading of Veradigm

A hedge fund recently bought a new stake in Veradigm stock. Tyro Capital Management LLC purchased a new position in shares of Veradigm Inc. (NASDAQ:MDRXFree Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,176,015 shares of the software maker’s stock, valued at approximately $9,055,000. Veradigm comprises 5.2% of Tyro Capital Management LLC’s investment portfolio, making the stock its 10th largest holding. Tyro Capital Management LLC owned about 1.08% of Veradigm as of its most recent filing with the Securities and Exchange Commission (SEC).

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.